EUVIMEDEUVIMED entdecken
Crossref

Changyanning tablet alleviates Crohn's disease by inhibiting GPX4-mediated ferroptosis

Ying Huang, Qing Ru, Haonan Ruan, Jing Zhang, Yunyun Wang, Chuang Wang, Changyong Chen, Defa Yu, Jiaoyang Luo, Meihua Yang

Journal of Ethnopharmacology · 2025-02 · 342 · 119415

DOI: 10.1016/j.jep.2025.119415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025-02. Verfasst von Ying Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Deve…. Hauptthemen laut MEDLINE: Ferroptosis, Drugs, Chinese Herbal, Crohn Disease, Phospholipid Hydroperoxide Glutathione Peroxidase. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Changyanning tablets (CYN) are a marketed traditional Chinese medicine composed of Diijincao (Euphorbia humifusa Willd.), Jinmaoercao (Hedyotis chrysotricha (Palib.) Merr.), Zhangshugen (root of Cinnamomum camphora (L.) J.Presl), Xiangru (Elsholtzia ciliate (Thunb.) Hyl.), and Fengxiangshuye (leaf of Liquidambar formosana Hance). They possess the functions of clearing heat, removing dampness, and regulating qi. CYN is used for the treatment of diarrhea and dysentery caused by damp heat in the large intestine, with symptoms such as diarrhea, or stools with pus and blood, tenesmus, abdominal pain and distension, acute and chronic gastroenteritis, diarrhea, bacterial diarrhea, and indigestion in children. AIM OF THE STUDY: This study aims to explore the intervention effects of CYN on Crohn's disease (CD) and its potential mechanisms. MATERIALS AND METHODS: The therapeutic effect and potential mechanism of CYN on CD were investigated based on the 2,4,6-Trinitrobenzenesulfonic acid solution (TNBS)-induced rat model. In vivo and in vitro experiments confirmed that CYN can alleviate CD by inhibiting GPX4-mediated ferroptosis. siRNA was used to knock down GPX4 for reverse validation. Finally, active components of CYN inhibiting ferroptosis were identified using UPLC-MS and the RSL3-induced HCoEpiC ferroptosis cell model. RESULTS: CYN significantly improved ferroptosis-related indicators (GSH, MDA, GPX4, and SLC7A11) in the colons of TNBS-induced CD rats. Screening with three ferroptosis inducers (RSL3, FINO2, and erastin) revealed that CYN was most effective against RSL3 (a ferroptosis inducer targeting GPX4)-induced apoptosis. Subsequently, the resistance effect of CYN on RSL3-induced ferroptosis was confirmed in vitro. Further in vivo experiments showed that CYN alleviated local CD-like intestinal injury induced by RSL3 enema. siRNA knockdown of GPX4 in HCoEpiC cells further validated GPX4 as major target of CYN in inhibiting ferroptosis. Finally, UPLC-MS and in vitro experiments identified rutin, rosmarinic acid, and kaempferol-3-O-sophoroside as key active components of CYN for inhibiting ferroptosis. CONCLUSIONS: CYN alleviates CD by inhibiting GPX4-mediated ferroptosis, highlighting its clinical potential for treating CD and enhancing the understanding of the pathogenic and therapeutic mechanisms associated with CD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisDrugs, Chinese HerbalCrohn DiseasePhospholipid Hydroperoxide Glutathione PeroxidaseAnimalsHumansMaleRats, Sprague-DawleyRatsTabletsDisease Models, Animal

Stichwörter der Autor:innen

Changyanning tabletCrohn's diseaseFerroptosisGPX4

Substanzen

Drugs, Chinese HerbalPhospholipid Hydroperoxide Glutathione PeroxidaseTablets

Autor:innen und Institutionen

  • Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical Co…
  • Jiangxi Kangenbei Traditional Chinese Medicine Co., Ltd., Shangrao, 334400, China. Electronic address: yudefa67@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Huang, Y., Ru, Q., Ruan, H., Zhang, J., Wang, Y., Wang, C., Chen, C., Yu, D., Luo, J., & Yang, M. (2025). Changyanning tablet alleviates Crohn's disease by inhibiting GPX4-mediated ferroptosis. Journal of Ethnopharmacology, 342, 119415. https://doi.org/10.1016/j.jep.2025.119415

Vancouver

Huang Y, Ru Q, Ruan H, Zhang J, Wang Y, Wang C, et al. Changyanning tablet alleviates Crohn's disease by inhibiting GPX4-mediated ferroptosis. Journal of Ethnopharmacology. 2025;342:119415. doi:10.1016/j.jep.2025.119415

BibTeX
@article{Huang2025,
  author = {Huang, Ying and Ru, Qing and Ruan, Haonan and Zhang, Jing and Wang, Yunyun and Wang, Chuang and Chen, Changyong and Yu, Defa and Luo, Jiaoyang and Yang, Meihua},
  title = {Changyanning tablet alleviates Crohn's disease by inhibiting GPX4-mediated ferroptosis},
  journal = {Journal of Ethnopharmacology},
  year = {2025},
  volume = {342},
  pages = {119415},
  doi = {10.1016/j.jep.2025.119415}
}
Kostenlos starten →